Full name
ART SOLUTIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,5 | 1,9 | 0,1 | -92,6 |
Gross profit (loss) | 2,4 | 1,9 | 0,1 | -92,4 |
EBITDA | 2,5 | 2 | 0,1 | -92,6 |
Short time liabilities | 0,7 | 1 | 0,8 | -20 |
Other operating costs | 0 | 0 | 0 | -100 |
Income tax | -44,8 | |||
Equity capital | 2,8 | 1,5 | 1,4 | -4,9 |
Operating profit (EBIT) | 2,5 | 1,9 | 0,1 | -92,6 |
Assets | 3,5 | 2,5 | 2,3 | -11 |
Net profit (loss) | 2,2 | 1,5 | 0,1 | -91,5 |
Cash | 2 | 1,7 | 1,5 | -12,3 |
Net income from sale | 9,3 | 8,5 | 0,6 | -93 |
Liabilities and provisions for liabilities | 0,7 | 1 | 0,8 | -20 |
Working assets | 3,3 | 2,3 | 2,1 | -11,6 |
Other income costs | 0 | 0 | 0 | -100 |
Depreciation | 0 | 0,1 | 0 | -92,3 |
Basic operational activity income | -∞ | |||
% | % | % | p.p. | |
Profitability of capital | 78,2 | 99,5 | 8,9 | -90,6 |
Equity capital to total assets | 79,2 | 59,9 | 63,9 | 4 |
Gross profit margin | 25,9 | 21,7 | 23,8 | 2,1 |
EBITDA Margin | 27,1 | 23 | 24,5 | 1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 44 | 500 | 456 |
Current financial liquidity indicator | 4.454554557800293 | 2.3041718006134033 | 2.544541835784912 | 0,2 |
Net dept to EBITDA | -0.7913604974746704 | -0.881971538066864 | -10.426239013671875 | -9,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane